Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HPTN 076: Safety of Injectable Rilpivirine for HIV PrEP
NCT02165202Phase 2Completed
- Sponsor
- PATH
- Start
- Oct 2014
- Primary completion
- Apr 2015
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of rilpivirine in human immunodeficiency virus infection (HIV), sponsored by PATH. Started Oct 2014; status: completed.
02
Drugs
rilpivirine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02165202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02165202.